The role of radiological and hybrid imaging for muscle metastases: a systematic review.
Gastrointestinal Neoplasms
/ pathology
Humans
Lung Neoplasms
/ pathology
Magnetic Resonance Imaging
Multimodal Imaging
Muscle Neoplasms
/ diagnostic imaging
Muscle, Skeletal
/ diagnostic imaging
Neoplasms, Unknown Primary
Positron Emission Tomography Computed Tomography
Positron-Emission Tomography
Prognosis
Tomography, X-Ray Computed
Torso
Urologic Neoplasms
/ pathology
Magnetic resonance
Metastasis
Multislice computed tomography
Muscles
Positron emission tomography-computed tomography
Journal
European radiology
ISSN: 1432-1084
Titre abrégé: Eur Radiol
Pays: Germany
ID NLM: 9114774
Informations de publication
Date de publication:
Apr 2020
Apr 2020
Historique:
received:
06
09
2019
accepted:
29
10
2019
revised:
22
10
2019
pubmed:
14
12
2019
medline:
21
10
2020
entrez:
14
12
2019
Statut:
ppublish
Résumé
Skeletal muscle metastases (SMM) are a rare entity, mainly detected at autopsy. Nevertheless, radiological and nuclear medicine imaging can contribute to the diagnosis with a significant impact on the treatment and prognosis of neoplastic patients. This study aimed to systematically review the features of SMM at imaging considering the primary tumors and the sites of occurrence. We conducted a systematic search of three electronic database (i.e., PubMed, Science Direct, and Web of Science) up to May 2019, without any language or time interval restriction. Two reviewers performed the search and selection process, data extraction, and synthesis. We resolved disagreements by consensus and/or involving a third reviewer. The included studies have been classified according to the Oxford Centre for Evidence Based Medicine (CEBM) grading system. Out of 8598 and 1077 articles respectively for radiological and hybrid imaging, 29 papers were included. According to CEBM, twelve were level 4. Computed tomography (CT) is mainly applied and, despite the existence of CT and magnetic resonance-based classifications, these are rarely used. Positron emission tomography/CT allowed the detection of small and subtle lesion also in the extremities. Muscles of the trunk were mostly affected and mainly respiratory tumors are associated with this type of metastatic spread. Radiological and hybrid imaging allow a precise characterization of SMM. However, a more systematic approach, including also the application of available classification systems, may increase the diagnostic accuracy for this rare type of metastases. • Skeletal muscle metastases have heterogeneous characteristics at imaging but mostly abscess-like features and high metabolic activity are described. • Skeletal muscle metastases mainly affect the muscles of the trunk. • Pulmonary, urological, and gastrointestinal cancers are the most frequent cause of skeletal muscle metastases.
Identifiants
pubmed: 31834507
doi: 10.1007/s00330-019-06555-4
pii: 10.1007/s00330-019-06555-4
doi:
Types de publication
Journal Article
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
2209-2219Références
Seely S (1980) Possible reasons for the high resistance of muscle to cancer. Med Hypotheses 6:133–137
doi: 10.1016/0306-9877(80)90079-1
Acinas Garcia O, Fernandez FA, Satue EG, Buelta L, Val-Bernal JF (1984) Metastasis of malignant neoplasms to skeletal muscle. Rev Esp Oncol 31:57–67
Weiss L (1989) Biomechanical destruction of cancer cells in skeletal muscle: a rate-regulator for hematogenous metastasis. Clin Exp Metastasis 7:483–491
doi: 10.1007/BF01753809
Pearson CM (1959) Incidence and type of pathologic alterations observed in muscle in a routine autopsy survey. Neurology 9:757–766
doi: 10.1212/WNL.9.11.757
Sudo A, Ogihara Y, Shiokawa Y, Fujinami S, Sekiguchi S (1993) Intramuscular metastasis of carcinoma. Clin Orthop Relat Res 296:213–217
Abulafia O, Sherer DM, Fultz PJ (1994) Computed tomographic detection of asymptomatic striated muscle metastasis from ovarian carcinoma. Am J Obstet Gynecol 171:560–561
doi: 10.1016/0002-9378(94)90301-8
Bocchino M, Valente T, Somma F, de Rosa I, Bifulco M, Rea G (2014) Detection of skeletal muscle metastases on initial staging of lung cancer: a retrospective case series. Jpn J Radiol 32:164–171
doi: 10.1007/s11604-014-0281-5
Sridhar KS, Rao RK, Kunhardt B (1987) Skeletal muscle metastases from lung cancer. Cancer 59:1530–1534
doi: 10.1002/1097-0142(19870415)59:8<1530::AID-CNCR2820590824>3.0.CO;2-H
Sersar SI (2009) Skeletal muscle metastasis secondary to lung cancer. South Med J 102:14–15
doi: 10.1097/SMJ.0b013e31818fa11c
Haygood TM, Sayyouh M, Wong J et al (2015) Skeletal muscle metastasis from renal cell carcinoma 21 cases and review of the literature. Sultan Qaboos Univ Med J 15:327–337
doi: 10.18295/squmj.2015.15.03.005
Li Q, Wang L, Pan S et al (2016) Skeletal muscle metastases on magnetic resonance imaging: analysis of 31 cases. Contemp Oncol (Pozn) 20:242–250
Das S, Pineda G, Goff L, Sobel R, Berlin J, Fisher G (2018) The eye of the beholder: orbital metastases from midgut neuroendocrine tumors, a two institution experience. Cancer Imaging 18(1):47. https://doi.org/10.1186/s40644-018-0181-5
doi: 10.1186/s40644-018-0181-5
pubmed: 30522522
pmcid: 6282338
Greene DP, Shield DR, Shields CL et al (2014) Cutaneous melanoma metastatic to the orbit: review of 15 cases. Ophthalmic Plast Reconstr Surg 30:233–237
Gupta A, Chazen JL, Phillips CD (2011) Carcinoid tumor metastases to the extraocular muscles: MR imaging and CT findings and review of the literature. AJNR Am J Neuroradiol 32:1208
doi: 10.3174/ajnr.A2470
Kobayashi T, Kawai H, Nakano O et al (2018) Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intra-arterial therapies. BMC Cancer 18:756
doi: 10.1186/s12885-018-4673-2
Limpawattana P, Theerakulpisut D, Wirasorn K, Sookprasert A, Khuntikeo N, Chindaprasirt J (2018) The impact of skeletal muscle mass on survival outcome in biliary tract cancer patients. PLoS One 13(10):e0204985
doi: 10.1371/journal.pone.0204985
Pretorius ES, Fishman EK (2000) Helical CT of skeletal muscle metastases from primary carcinomas. AJR Am J Roentgenol 174:401–404
Arpaci T, Ugurluer G, Akbas T, Arpaci RB, Serin M (2012) Imaging of the skeletal muscle metastases. Eur Rev Med Pharmacol Sci 16:2057–2063
pubmed: 23280019
Surov A, Kohler J, Wienke A et al (2014) Muscle metastases: comparison of features in different primary tumours. Cancer Imaging 14:21
doi: 10.1186/1470-7330-14-21
Surov A, Nagata S, Abd Razek AA, Tirumani SH, Wienke A, Kahn T (2015) Comparison of ADC values in different malignancies of the skeletal musculature: a multicentric analysis. Skeletal Radiol 44:995–1000
doi: 10.1007/s00256-015-2141-5
Emmering J, Vogel WV, Stokkel MP (2012) Intramuscular metastases on FDG PET-CT: a review of the literature. Nucl Med Commun 33(2):117–120. https://doi.org/10.1097/MNM.0b013e32834e3ad0
doi: 10.1097/MNM.0b013e32834e3ad0
pubmed: 22124361
Surov A, Hainz M, Holzhausen H-J et al (2010) Skeletal muscle metastases: primary tumours, prevalence, and radiological features. Eur Radiol 20:649–658
doi: 10.1007/s00330-009-1577-1
OCEBM Levels of Evidence Working Group. “The Oxford 2011 Levels of Evidence”. Oxford Centre for Evidence-Based Medicine. http://www.cebm.net/index.aspx?o=5653 . Accessed 3 March 2019
Haygood TM, Wong J, Lin JC et al (2012) Skeletal muscle metastases: a three-part study of a not-so-rare entity. Skeletal Radiol 41(8):899–909. https://doi.org/10.1007/s00256-011-1319-8
doi: 10.1007/s00256-011-1319-8
pubmed: 22101865
Kim YW, Seo KJ, Lee SL et al (2013) Skeletal muscle metastases from breast cancer: two case reports. J Breast Cancer 16:117–121
doi: 10.4048/jbc.2013.16.1.117
Yoshimura Y, Isobel K, Koike T, Arai H, Aoki K, Kato H (2011) Metastatic carcinoma to subcutaneous tissue and skeletal muscle: clinicopathological features in 11 cases. Jpn J Clin Oncol 41:358–364
doi: 10.1093/jjco/hyq199
Nabi G, Gupta NP, Gandhi D (2003) Skeletal muscle metastasis from transitional cell carcinoma of the urinary bladder: clinicoradiological features. Clin Radiol 58:883–885
doi: 10.1016/S0009-9260(03)00234-4
Schultz SR, Bree RL, Schwab RE, Raiss G (1986) CT detection of skeletal muscle metastases. J Comput Assist Tomogr 10:81–83
doi: 10.1097/00004728-198601000-00018
Williams JB, Youngberg RA, Bui-Mansfield LT, Pitcher JD (1997) MR Imaging of skeletal muscle metastases. AJR Am J Roentgenol 168:555–557
Lekse JM, Zhang J, Mawn LA (2003) Metastatic gastroesophageal junction adenocarcinoma to the extraocular muscles. Ophthalmology 110:318–321
doi: 10.1016/S0161-6420(02)01559-2
Yang WT, Yeo W, Metreweli C (1999) Imaging of iliopsoas metastasis. Clin Radiol 54:85–89
doi: 10.1016/S0009-9260(99)91065-6
Hoshi M, Taguchi S, Ieguchi M (2010) Skeletal metastasis form sarcoma: a report of three cases. Eur J Orthop Surg Traumatol 20:317–322
doi: 10.1007/s00590-009-0568-x
Soker G, Soker E, Gulek B et al (2014) Rotator cuff metastases: a report of two cases with literature review. N Am J Med Sci 6:653–656
doi: 10.4103/1947-2714.147988
Tuoheti Y, Okada K, Osanai T et al (2004) Skeletal muscle metastases of carcinoma: a clinicopathological study of 12 cases. Jpn J Clin Oncol 34:210–214
doi: 10.1093/jjco/hyh036
Crespi G, Deschovich MC, Giannoni M, Grillo F (1990) Metastases of the skeletal muscles. The echographic aspects. Radiol Med 79:553–554
pubmed: 2193327
Singh AK, Gervais DA, Hahn PF, Mueller PR (2008) Neoplastic iliopsoas masses in oncology patients: CT findings. Abdom Imaging 33:493–497
doi: 10.1007/s00261-007-9274-5
Cincibuch J, Mysliveček M, Melichar B et al (2012) Metastases of esophageal carcinoma to skeletal muscle: single center experience. World J Gastroenterol 18(35):4962–4966
doi: 10.3748/wjg.v18.i35.4962
Liu Y (2019) Focal mass-like cardiac uptake on oncologic FDG PET/CT: Real lesion or atypical pattern of physiologic uptake? J Nucl Cardiol 26(4):1205–1211. https://doi.org/10.1007/s12350-018-01524-8
doi: 10.1007/s12350-018-01524-8
pubmed: 30443752
Nocuń A, Chrapko B (2015) Multiple and solitary skeletal muscle metastases on 18F-FDG PET/CT imaging. Nucl Med Commun 36(11):1091–1099. https://doi.org/10.1097/MNM.0000000000000368
doi: 10.1097/MNM.0000000000000368
pubmed: 26275016
Noordzij W, van Beek AP, Tio RA et al (2014) Myocardial metastases on 6-[18F] fluoro-L-DOPA PET/CT: a retrospective analysis of 116 serotonin producing neuroendocrine tumour patients. PLoS One 9(11):e112278. https://doi.org/10.1371/journal.pone.0112278
doi: 10.1371/journal.pone.0112278
pubmed: 25397775
pmcid: 4232397
Savas K, Pinar KZ, Sevda KS et al (2015) Haematogenous muscular metastasis of non-small cell lung cancer in F-18 fluorodeoxyglucose positron emission tomography/computed tomography. Contemp Oncol (Pozn) 19(3):241–245. https://doi.org/10.5114/wo.2014.46044
doi: 10.5114/wo.2014.46044
So Y, Yi JG, Song I et al (2015) Detection of skeletal muscle metastasis: torso FDG PET-CT versus contrast-enhanced chest or abdomen CT. Acta Radiol 56(7):860–866. https://doi.org/10.1177/0284185114556927
doi: 10.1177/0284185114556927
pubmed: 25406434
Surov A, Pawelka MK, Wienke A, Schramm D (2014) PET/CT imaging of skeletal muscle metastases. Acta Radiol 55(1):101–106. https://doi.org/10.1177/0284185113493086
doi: 10.1177/0284185113493086
pubmed: 23884841
Berzaczy D, Giraudo C, Haug AR et al (2017) Whole-body 68Ga-DOTANOC PET/MRI versus 68Ga-DOTANOC PET/CT in patients with neuroendocrine tumors: a prospective study in 28 patients. Clin Nucl Med 42(9):669–674. https://doi.org/10.1097/RLU.0000000000001753
doi: 10.1097/RLU.0000000000001753
pubmed: 28682844
pmcid: 5636054
Giraudo C, Raderer M, Karanikas G et al (2016) 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance in lymphoma: comparison with 18F-fluorodeoxyglucose positron emission tomography/computed tomography and with the addition of magnetic resonance diffusion-weighted imaging. Invest Radiol 51(3):163–169. https://doi.org/10.1097/RLI.0000000000000218
doi: 10.1097/RLI.0000000000000218
pubmed: 26784400
pmcid: 4747979
Umutlu L, Beyer T, Grueneisen JS et al (2019) Whole-body [18F]-FDG-PET/MRI for oncology: a consensus recommendation. Rofo 191(4):289–297. https://doi.org/10.1055/a-0828-8654
doi: 10.1055/a-0828-8654
pubmed: 30818411
Kwon HW, Becker AK, Goo JM, Cheon GJ (2017) FDG whole-body PET/MRI in oncology: a systematic review. Nucl Med Mol Imaging 51(1):22–31. https://doi.org/10.1007/s13139-016-0411-3
doi: 10.1007/s13139-016-0411-3
pubmed: 28250855
Ladd SC (2009) Whole-body MRI as a screening tool? Eur J Radiol 70(3):452–462. https://doi.org/10.1016/j.ejrad.2009.02.011
doi: 10.1016/j.ejrad.2009.02.011
pubmed: 19345540
Tarnoki DL, Tarnoki AD, Richter A, Karlinger K, Berczi V, Pickuth D (2015) Clinical value of whole-body magnetic resonance imaging in health screening of general adult population. Radiol Oncol 49(1):10–16. https://doi.org/10.2478/raon-2014-0031
doi: 10.2478/raon-2014-0031
pubmed: 25810696
pmcid: 4362601
Ulus S, Suleyman E, Ozcan UA, Karaarslan E (2016) Whole-body MRI screening in asymptomatic subjects; preliminary experience and long-term follow-up findings. Pol J Radiol 81:407–414. https://doi.org/10.12659/PJR.897570
doi: 10.12659/PJR.897570
pubmed: 27635171
pmcid: 5008738
Mayerhoefer ME, Prosch H, Beer L et al (2019) PET/MRI versus PET/CT in oncology: a prospective single-center study of 330 examinations focusing on implications for patient management and cost considerations. Eur J Nucl Med Mol Imaging. https://doi.org/10.1007/s00259-019-04452-y